Summary:
This is a Phase 4, multicenter, safety and efficacy study of Pegloticase and an investigational medication on patients with uncontrolled gout.
- Adult men and women over 18 years old
- Uncontrolled Gout with symptoms
- At least one tophus
- Recurrent flares
- Chronic gouty arthritis
Qualified Participants May Receive: